Which has stronger valuation & earnings, DXCM or GMED?

DexCom has higher revenue and earnings than Globus Medical. Globus Medical is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DexCom $4.66B 7.40 $836.30M $2.53 36.16 Globus Medical $3.14B 3.72 $537.87M $3.91 22.02

Is DXCM or GMED more profitable?

DexCom has a net margin of 20.12% compared to Globus Medical's net margin of 17.02%. DexCom's return on equity of 35.94% beat Globus Medical's return on equity. Company Net Margins Return on Equity Return on Assets DexCom 20.12% 35.94% 14.75% Globus Medical 17.02% 14.57% 12.62%

Does the media favor DXCM or GMED?

In the previous week, Globus Medical had 7 more articles in the media than DexCom. MarketBeat recorded 16 mentions for Globus Medical and 9 mentions for DexCom. DexCom's average media sentiment score of 0.99 beat Globus Medical's score of 0.70 indicating that DexCom is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DexCom 5 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Globus Medical 6 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor GEHC or GMED?

In the previous week, Globus Medical had 5 more articles in the media than GE HealthCare Technologies. MarketBeat recorded 16 mentions for Globus Medical and 11 mentions for GE HealthCare Technologies. GE HealthCare Technologies' average media sentiment score of 1.04 beat Globus Medical's score of 0.70 indicating that GE HealthCare Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GE HealthCare Technologies 5 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Globus Medical 6 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, GMED or RMD?

ResMed has higher revenue and earnings than Globus Medical. ResMed is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Globus Medical $3.14B 3.72 $537.87M $3.91 22.02 ResMed $5.65B 5.82 $1.52B $10.43 21.76

Is GMED or RMD more profitable?

ResMed has a net margin of 26.94% compared to Globus Medical's net margin of 17.02%. ResMed's return on equity of 25.58% beat Globus Medical's return on equity. Company Net Margins Return on Equity Return on Assets Globus Medical 17.02% 14.57% 12.62% ResMed 26.94% 25.58% 18.89%

Does the media prefer GMED or RMD?

In the previous week, ResMed had 12 more articles in the media than Globus Medical. MarketBeat recorded 28 mentions for ResMed and 16 mentions for Globus Medical. Globus Medical's average media sentiment score of 0.70 beat ResMed's score of 0.52 indicating that Globus Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Globus Medical 6 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive ResMed 7 Very Positive mention(s) 10 Positive mention(s) 3 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate PHG or GMED?

Globus Medical has a consensus price target of $101.77, indicating a potential upside of 18.22%. Given Globus Medical's stronger consensus rating and higher probable upside, analysts plainly believe Globus Medical is more favorable than Koninklijke Philips. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Koninklijke Philips 1 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.80 Globus Medical 0 Sell rating(s) 5 Hold rating(s) 9 Buy rating(s) 3 Strong Buy rating(s) 2.88

Does the media prefer PHG or GMED?

In the previous week, Globus Medical had 9 more articles in the media than Koninklijke Philips. MarketBeat recorded 16 mentions for Globus Medical and 7 mentions for Koninklijke Philips. Globus Medical's average media sentiment score of 0.70 beat Koninklijke Philips' score of 0.57 indicating that Globus Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Koninklijke Philips 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Globus Medical 6 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, STE or GMED?

STERIS has higher revenue and earnings than Globus Medical. Globus Medical is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio STERIS $5.94B 3.88 $782.30M $8.18 28.85 Globus Medical $3.14B 3.72 $537.87M $3.91 22.02

Is STE or GMED more profitable?

Globus Medical has a net margin of 17.02% compared to STERIS's net margin of 13.34%. Globus Medical's return on equity of 14.57% beat STERIS's return on equity. Company Net Margins Return on Equity Return on Assets STERIS 13.34% 14.34% 9.66% Globus Medical 17.02% 14.57% 12.62%

Does the media favor STE or GMED?

In the previous week, Globus Medical had 2 more articles in the media than STERIS. MarketBeat recorded 16 mentions for Globus Medical and 14 mentions for STERIS. Globus Medical's average media sentiment score of 0.70 beat STERIS's score of 0.23 indicating that Globus Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STERIS 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Globus Medical 6 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Globus Medical (GMED) Competitors

$86.09 +0.42 (+0.49%)

Closing price 08/13/2026 03:59 PM Eastern

Extended Trading

$85.58 -0.51 (-0.59%)

As of 09:12 AM Eastern

Compare

GMED vs. DXCM, GEHC, RMD, PHG, and STE

Should you buy Globus Medical stock or one of its competitors? Globus Medical's main competitors and comparable companies include DexCom (DXCM), GE HealthCare Technologies (GEHC), ResMed (RMD), Koninklijke Philips (PHG), and STERIS (STE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Globus Medical compare to DexCom?

DexCom (NASDAQ:DXCM) and Globus Medical (NYSE:GMED) are both large-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk, analyst recommendations and media sentiment.

DexCom currently has a consensus price target of $88.71, indicating a potential downside of 3.03%. Globus Medical has a consensus price target of $101.77, indicating a potential upside of 18.22%. Given Globus Medical's higher probable upside, analysts plainly believe Globus Medical is more favorable than DexCom.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DexCom	1 Sell rating(s)	3 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.89
Globus Medical	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.88

DexCom has a beta of 1.41, suggesting that its stock price is 41% more volatile than the broader market. Comparatively, Globus Medical has a beta of 0.95, suggesting that its stock price is 5% less volatile than the broader market.

97.8% of DexCom shares are held by institutional investors. Comparatively, 95.2% of Globus Medical shares are held by institutional investors. 0.3% of DexCom shares are held by company insiders. Comparatively, 18.4% of Globus Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

DexCom has a net margin of 20.12% compared to Globus Medical's net margin of 17.02%. DexCom's return on equity of 35.94% beat Globus Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DexCom	20.12%	35.94%	14.75%
Globus Medical	17.02%	14.57%	12.62%

In the previous week, Globus Medical had 7 more articles in the media than DexCom. MarketBeat recorded 16 mentions for Globus Medical and 9 mentions for DexCom. DexCom's average media sentiment score of 0.99 beat Globus Medical's score of 0.70 indicating that DexCom is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DexCom	5 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Globus Medical	6 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

DexCom has higher revenue and earnings than Globus Medical. Globus Medical is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DexCom	$4.66B	7.40	$836.30M	$2.53	36.16
Globus Medical	$3.14B	3.72	$537.87M	$3.91	22.02

Summary

DexCom beats Globus Medical on 12 of the 17 factors compared between the two stocks.

How does Globus Medical compare to GE HealthCare Technologies?

GE HealthCare Technologies (NASDAQ:GEHC) and Globus Medical (NYSE:GMED) are both large-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, media sentiment, institutional ownership and dividends.

GE HealthCare Technologies has higher revenue and earnings than Globus Medical. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GE HealthCare Technologies	$20.63B	1.62	$2.08B	$4.36	16.92
Globus Medical	$3.14B	3.72	$537.87M	$3.91	22.02

82.1% of GE HealthCare Technologies shares are owned by institutional investors. Comparatively, 95.2% of Globus Medical shares are owned by institutional investors. 0.4% of GE HealthCare Technologies shares are owned by company insiders. Comparatively, 18.4% of Globus Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

GE HealthCare Technologies has a beta of 0.69, meaning that its stock price is 31% less volatile than the broader market. Comparatively, Globus Medical has a beta of 0.95, meaning that its stock price is 5% less volatile than the broader market.

In the previous week, Globus Medical had 5 more articles in the media than GE HealthCare Technologies. MarketBeat recorded 16 mentions for Globus Medical and 11 mentions for GE HealthCare Technologies. GE HealthCare Technologies' average media sentiment score of 1.04 beat Globus Medical's score of 0.70 indicating that GE HealthCare Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GE HealthCare Technologies	5 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Globus Medical	6 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Globus Medical has a net margin of 17.02% compared to GE HealthCare Technologies' net margin of 9.33%. GE HealthCare Technologies' return on equity of 20.12% beat Globus Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GE HealthCare Technologies	9.33%	20.12%	5.74%
Globus Medical	17.02%	14.57%	12.62%

GE HealthCare Technologies currently has a consensus price target of $77.73, indicating a potential upside of 5.34%. Globus Medical has a consensus price target of $101.77, indicating a potential upside of 18.22%. Given Globus Medical's stronger consensus rating and higher probable upside, analysts plainly believe Globus Medical is more favorable than GE HealthCare Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GE HealthCare Technologies	0 Sell rating(s)	11 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.48
Globus Medical	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.88

Summary

Globus Medical beats GE HealthCare Technologies on 11 of the 17 factors compared between the two stocks.

How does Globus Medical compare to ResMed?

Globus Medical (NYSE:GMED) and ResMed (NYSE:RMD) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, media sentiment, risk and analyst recommendations.

95.2% of Globus Medical shares are held by institutional investors. Comparatively, 55.0% of ResMed shares are held by institutional investors. 18.4% of Globus Medical shares are held by company insiders. Comparatively, 0.7% of ResMed shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

ResMed has higher revenue and earnings than Globus Medical. ResMed is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Globus Medical	$3.14B	3.72	$537.87M	$3.91	22.02
ResMed	$5.65B	5.82	$1.52B	$10.43	21.76

Globus Medical currently has a consensus target price of $101.77, indicating a potential upside of 18.22%. ResMed has a consensus target price of $240.17, indicating a potential upside of 5.80%. Given Globus Medical's stronger consensus rating and higher probable upside, research analysts clearly believe Globus Medical is more favorable than ResMed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Globus Medical	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.88
ResMed	0 Sell rating(s)	9 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.44

Globus Medical has a beta of 0.95, suggesting that its share price is 5% less volatile than the broader market. Comparatively, ResMed has a beta of 0.76, suggesting that its share price is 24% less volatile than the broader market.

In the previous week, ResMed had 12 more articles in the media than Globus Medical. MarketBeat recorded 28 mentions for ResMed and 16 mentions for Globus Medical. Globus Medical's average media sentiment score of 0.70 beat ResMed's score of 0.52 indicating that Globus Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Globus Medical	6 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
ResMed	7 Very Positive mention(s)	10 Positive mention(s)	3 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

ResMed has a net margin of 26.94% compared to Globus Medical's net margin of 17.02%. ResMed's return on equity of 25.58% beat Globus Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Globus Medical	17.02%	14.57%	12.62%
ResMed	26.94%	25.58%	18.89%

Summary

Globus Medical beats ResMed on 9 of the 17 factors compared between the two stocks.

How does Globus Medical compare to Koninklijke Philips?

Koninklijke Philips (NYSE:PHG) and Globus Medical (NYSE:GMED) are both large-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, media sentiment, earnings, valuation, risk and analyst recommendations.

Koninklijke Philips has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market. Comparatively, Globus Medical has a beta of 0.95, suggesting that its stock price is 5% less volatile than the broader market.

In the previous week, Globus Medical had 9 more articles in the media than Koninklijke Philips. MarketBeat recorded 16 mentions for Globus Medical and 7 mentions for Koninklijke Philips. Globus Medical's average media sentiment score of 0.70 beat Koninklijke Philips' score of 0.57 indicating that Globus Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Koninklijke Philips	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Globus Medical	6 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Globus Medical has a net margin of 17.02% compared to Koninklijke Philips' net margin of 6.30%. Globus Medical's return on equity of 14.57% beat Koninklijke Philips' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Koninklijke Philips	6.30%	14.38%	5.96%
Globus Medical	17.02%	14.57%	12.62%

Koninklijke Philips has higher revenue and earnings than Globus Medical. Koninklijke Philips is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Koninklijke Philips	$20.17B	1.33	$1.01B	$1.36	20.13
Globus Medical	$3.14B	3.72	$537.87M	$3.91	22.02

Globus Medical has a consensus price target of $101.77, indicating a potential upside of 18.22%. Given Globus Medical's stronger consensus rating and higher probable upside, analysts plainly believe Globus Medical is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Koninklijke Philips	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80
Globus Medical	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.88

13.7% of Koninklijke Philips shares are held by institutional investors. Comparatively, 95.2% of Globus Medical shares are held by institutional investors. 18.4% of Globus Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Globus Medical beats Koninklijke Philips on 15 of the 17 factors compared between the two stocks.

How does Globus Medical compare to STERIS?

STERIS (NYSE:STE) and Globus Medical (NYSE:GMED) are both large-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, analyst recommendations, risk, media sentiment, earnings and dividends.

STERIS currently has a consensus price target of $271.33, suggesting a potential upside of 14.97%. Globus Medical has a consensus price target of $101.77, suggesting a potential upside of 18.22%. Given Globus Medical's stronger consensus rating and higher possible upside, analysts clearly believe Globus Medical is more favorable than STERIS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STERIS	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
Globus Medical	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.88

Globus Medical has a net margin of 17.02% compared to STERIS's net margin of 13.34%. Globus Medical's return on equity of 14.57% beat STERIS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
STERIS	13.34%	14.34%	9.66%
Globus Medical	17.02%	14.57%	12.62%

STERIS has higher revenue and earnings than Globus Medical. Globus Medical is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STERIS	$5.94B	3.88	$782.30M	$8.18	28.85
Globus Medical	$3.14B	3.72	$537.87M	$3.91	22.02

94.7% of STERIS shares are held by institutional investors. Comparatively, 95.2% of Globus Medical shares are held by institutional investors. 1.1% of STERIS shares are held by company insiders. Comparatively, 18.4% of Globus Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

STERIS has a beta of 0.91, suggesting that its stock price is 9% less volatile than the broader market. Comparatively, Globus Medical has a beta of 0.95, suggesting that its stock price is 5% less volatile than the broader market.

In the previous week, Globus Medical had 2 more articles in the media than STERIS. MarketBeat recorded 16 mentions for Globus Medical and 14 mentions for STERIS. Globus Medical's average media sentiment score of 0.70 beat STERIS's score of 0.23 indicating that Globus Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
STERIS	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
Globus Medical	6 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Globus Medical beats STERIS on 12 of the 17 factors compared between the two stocks.

Get Globus Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GMED and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GMED vs. The Competition

Export

Metric	Globus Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$11.67B	$5.94B	$7.07B	$24.28B
Dividend Yield	N/A	1.76%	2.58%	3.69%
P/E Ratio	22.02	26.47	269.63	30.23
Price / Sales	3.72	40.69	596.70	20.62
Price / Cash	13.64	33.59	70.53	33.80
Price / Book	2.45	5.90	13.11	6.69
Net Income	$537.87M	$148.67M	$3.45B	$1.06B
7 Day Performance	4.72%	1.87%	0.77%	0.45%
1 Month Performance	13.81%	4.66%	1.44%	3.07%
1 Year Performance	43.36%	8.98%	67.07%	18.36%

Globus Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GMED Globus Medical	3.7223 of 5 stars	$86.09 +0.5%	$101.77 +18.2%	+36.8%	$11.67B	$3.14B	22.02	6,000
DXCM DexCom	4.2068 of 5 stars	$87.31 +4.6%	$88.46 +1.3%	+14.4%	$31.49B	$4.66B	34.51	11,000	Analyst Upgrade
GEHC GE HealthCare Technologies	4.4221 of 5 stars	$69.73 +2.5%	$77.73 +11.5%	-2.0%	$30.72B	$21.27B	15.99	54,000	Positive News Analyst Upgrade
RMD ResMed	3.6062 of 5 stars	$215.12 +2.0%	$246.25 +14.5%	-21.2%	$30.60B	$5.54B	20.74	10,600	Analyst Upgrade Insider Trade
PHG Koninklijke Philips	2.7698 of 5 stars	$26.22 -0.3%	N/A	+0.3%	$25.85B	$20.17B	19.32	65,340	Short Interest Increase

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:GMED) was last updated on 8/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Globus Medical (GMED) Competitors

GMED vs. DXCM, GEHC, RMD, PHG, and STE

How does Globus Medical compare to DexCom?

Summary

How does Globus Medical compare to GE HealthCare Technologies?

Summary

How does Globus Medical compare to ResMed?

Summary

How does Globus Medical compare to Koninklijke Philips?

Summary

How does Globus Medical compare to STERIS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GMED vs. The Competition

Globus Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Globus Medical (GMED) Competitors

GMED vs. DXCM, GEHC, RMD, PHG, and STE

How does Globus Medical compare to DexCom?

Do analysts recommend DXCM or GMED?

Which has more risk and volatility, DXCM or GMED?

Do insiders & institutionals believe in DXCM or GMED?

Is DXCM or GMED more profitable?

Does the media favor DXCM or GMED?

Which has stronger valuation & earnings, DXCM or GMED?

Summary

How does Globus Medical compare to GE HealthCare Technologies?

Which has better earnings and valuation, GEHC or GMED?

Do institutionals & insiders have more ownership in GEHC or GMED?

Which has more risk and volatility, GEHC or GMED?

Does the media favor GEHC or GMED?

Is GEHC or GMED more profitable?

Do analysts rate GEHC or GMED?

Summary

How does Globus Medical compare to ResMed?

Do insiders & institutionals believe in GMED or RMD?

Which has stronger valuation and earnings, GMED or RMD?

Do analysts rate GMED or RMD?

Which has more risk & volatility, GMED or RMD?

Does the media prefer GMED or RMD?

Is GMED or RMD more profitable?

Summary

How does Globus Medical compare to Koninklijke Philips?

Which has more volatility & risk, PHG or GMED?

Does the media prefer PHG or GMED?

Is PHG or GMED more profitable?

Which has better earnings & valuation, PHG or GMED?

Do analysts rate PHG or GMED?

Do insiders and institutionals believe in PHG or GMED?

Summary

How does Globus Medical compare to STERIS?

Do analysts prefer STE or GMED?

Is STE or GMED more profitable?

Which has stronger earnings and valuation, STE or GMED?

Do insiders & institutionals hold more shares of STE or GMED?

Which has more volatility & risk, STE or GMED?

Does the media favor STE or GMED?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GMED vs. The Competition

Globus Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools